Drug Extravasation in Pediatric Oncology: Single Center Experience

Aim: The frequency of cytotoxic chemotherapy extravasation is uncertain. The aim of this study was to determine extravasation frequency and to verify the risk factors in our center.Materials and Methods: Hospital records of pediatric oncology patients at Uludağ University Faculty of Medicine, Depart...

Full description

Saved in:
Bibliographic Details
Main Author: Betül Sevinir
Format: Article
Language:English
Published: Galenos Publishing House 2008-06-01
Series:Güncel Pediatri
Subjects:
Online Access:http://www.guncelpediatri.com/yazilar.asp?yaziid=849&sayiid=
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: The frequency of cytotoxic chemotherapy extravasation is uncertain. The aim of this study was to determine extravasation frequency and to verify the risk factors in our center.Materials and Methods: Hospital records of pediatric oncology patients at Uludağ University Faculty of Medicine, Department of Pediatric Oncology between 2004-2007 were reviewed retrospectively. Number of the cases with chemotherapy extravasation, diagnosis, demographic and clinical features were recorded. Results: The incidence of cytotoxic drug extravasation in pediatric oncology cases was 0.4%. Forty-one percent of extravasations were observed in patients under 3 years The median extravasation time was 9th week of the chemotherapy. Most of the extravasation injuries were seen in outpatient clinic (77%) and mainly in cases who were having therapy weekly (59%). The most frequent site of extravasation was dorsal hand (82%). Causative drugs were vinca alkaloids, doxorubicin and dactinomycin.Conclusion: The incidence of chemotherapy induced extravasations were similar with literature. Young age and weekly chemotherapy were major risk factors in pediatric oncology cases. (Journal of Current Pediatrics 2008; 6: 1-4)
ISSN:1304-9054